💨 Abstract
Royalty Pharma reported second-quarter profit of $30 million, exceeding Wall Street expectations. The company earned $1.14 per share, adjusted for non-recurring costs, with revenue of $579 million. Adjusted revenue was $727 million. Royalty Pharma projects full-year revenue between $3.05 billion and $3.15 billion.
Courtesy: WTOP Staff
Suggested
James Patterson and Vicky Ward to write book on UnitedHealthcare CEO’s killing -
China solía multar a las parejas por tener demasiados hijos. Ahora no puede pagarles lo suficiente -
Este agricultor perdió la mitad de su fuerza laboral por las deportaciones. Ahora también está perdiendo su cosecha -
What kids say it would take to get them off their phones -
Survivors of Israel’s pager attack on Hezbollah last year struggle to recover -
Many Delaware beachgoers feel the sting of a blooming jellyfish population -
PHOTO ESSAY: Portraits of survivors of Israel’s pager attack on Hezbollah last year -
Study says ChatGPT giving teens dangerous advice on drugs, alcohol and suicide -
Estos son los países latinoamericanos que crecerán más (y menos) económicamente en 2025, según la Cepal -
Russia asks Central African Republic to replace Wagner with state-run Africa Corps and pay for it -